Merck
MRK
$130.38
Share price
2.20%
Change (1 day)
10.14%
Change (1 year)
Categories
Earnings for Merck (MRK)
Earnings in 2023 (TTM): $3.03 B
According to Merck's latest financial reports the company's current earnings (TTM) are $3.03 B. a decrease over its 2022 earnings that were of $17.40 B.The earnings displayed on this page is the company's Pretax Income.
Earnings history for Merck from 2001 to 2023
Annual earnings
| Year | Earnings | Change |
|---|---|---|
2023  | $3.03 B | -82.56% |
| 2022 | $17.40 B | 18.52% |
| 2021 | $14.68 B | 80.8% |
| 2020 | $8.12 B | -34.26% |
| 2019 | $12.35 B | 30.45% |
| 2018 | $9.47 B | 30.2% |
| 2017 | $7.27 B | 35.93% |
| 2016 | $5.35 B | -11.87% |
| 2015 | $6.07 B | -66.29% |
| 2014 | $18.01 B | 183.88% |
| 2013 | $6.34 B | -32.87% |
| 2012 | $9.45 B | 17.32% |
| 2011 | $8.05 B | 240.11% |
| 2010 | $2.36 B | -84.96% |
| 2009 | $15.74 B | 66.09% |
| 2008 | $9.48 B | 68.8% |
| 2007 | $5.61 B | 52.38% |
| 2006 | $3.68 B | -37.16% |
| 2005 | $5.86 B | -11.41% |
| 2004 | $6.62 B | -20.89% |
| 2003 | $8.37 B | -11.74% |
| 2002 | $9.48 B | -2.51% |
| 2001 | $9.72 B |
Earnings for similar companies or competitors
| Company | Earnings | Earnings differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $21.36 B | 603.89% | 🇺🇸 USA |
 Novartis NVS | $9.82 B | 223.79% | 🇨🇭 Switzerland |
 Pfizer PFE | $3.26 B | 7.64% | 🇺🇸 USA |
 Abbott Laboratories ABT | $6.66 B | 119.57% | 🇺🇸 USA |
 Eli Lilly LLY | $7.56 B | 149.13% | 🇺🇸 USA |
 Amgen AMGN | $7.85 B | 158.81% | 🇺🇸 USA |
 Sanofi SNY | $7.26 B | 139.24% | 🇫🇷 France |
 Bristol-Myers Squibb BMY | -$5.85 B | -292.62% | 🇺🇸 USA |
 GlaxoSmithKline GSK | $6.88 B | 126.86% | 🇬🇧 UK |
 Teva Pharmaceutical Industries TEVA | $0.40 B | -86.66% | 🇮🇱 Israel |